Institutional Approaches to Research Integrity in Ghana

Recent trends: Retractions of articles in the oncology field

Background

In recent years, there has been a surge in media reports on articles being retracted after publication. This issue has gained significant attention, particularly due to the consecutive large-scale retractions carried out by renowned international publishers, which have aroused widespread concern in the society.

Objective

To analyze the data of retracted articles and retraction trends.

Methods

The publications were searched through Web of Science Core Collection (WoSCC) database and imported into CiteSpace in plain text format, and visual analysis of countries, institutions, keywords, and subject areas were performed to reveal the trends of retracted articles and the worst areas of retraction.

Results

From 1990 to 2022, 21,568 retracted articles were retrieved, among which the number of retracted articles increased year by year. China is the country with the highest number of retracted articles; Islamic Azad University is the institution with the highest number of retracted articles. In the analysis of all retracted articles across different subject areas, the number of retracted articles in the field of oncology was the highest; In the keyword cluster analysis of retracted articles within the field of oncology, the most prominent category of retracted articles were related to pancreatic cancer.

Conclusions

Scientific and systematic analysis of retracted articles is conducive to improving the quality of papers, raising the level of human research, and cleaning up the research environment.

Assessment of the Operational Characteristics of Research Ethics Committees in Ghana

There were eighteen Research Ethics Committees (RECs) operating in Ghana as of December 2019 but no empirical assessment of their operational characteristics had been conducted. We assessed the characteristics of Ghanaian RECs using an existing Self-Assessment Tool for RECs in Developing Countries. We present results from nine RECs that participated in this nation-wide assessment. Our results indicate that the RECs are generally adherent to the recommendations in the Tool including being composed of members with diverse expertise. They also reviewed and approved research protocols as well as had access to some limited funding for their activities. There is no national policy on research human protections or an ethics authority to regulate the activities of the RECs. We recommend the establishment of this authority in Ghana while encouraging institutions to sustain efforts aimed at making their RECs operate independently.

A Review of Regulatory Frameworks Governing Biobanking in the Low and Middle Income Member Countries of BCNet

Biomedical research based on the sharing and use of ever larger volumes of samples and data is increasingly becoming an essential component of scientific discovery. The success of biobanking and genomic research is dependent on the broad sharing of resources for use by investigators. However, important ethical challenges need to be addressed for the sample and data sharing to be successful. Despite low- and middle-income countries (LMICs) carrying a higher burden of disease, biomedical research conducted to date has mainly focused on high-income countries. In order for LMICs to benefit from the advances in such research, normative documents (such as laws and guidelines) play a significant role in allowing LMIC projects to partake and be represented in global biomedical research. The administration and management of the ethical aspects of biobanking, including informed consent, are key components in ensuring that samples and data can legally and ethically be used and shared. As part of its support to the LMIC biobanks, the International Agency for Research on Cancer (IARC) established a biobank and population cohort building network (BCNet) in 2013 with the aims of providing support (including education and training) and facilitating the development and improvement of biobanking infrastructure in LMICs. A comparative analysis of the laws and guidelines in BCNet countries was completed to highlight some of the ethical and legal issues related to biobanking in LMICs and to identify examples of effective systems of governance already in operation.